메뉴 건너뛰기




Volumn 23, Issue 2, 2008, Pages 149-157

Recommendations for personalized dietary adjustments based on patient response to tetrahydrobiopterin (BH 4) in phenylketonuria

Author keywords

Diet; Kuvan; Phenylalanine restriction; Phenylalanine tolerance; Phenylketonuria; Sapropterin dihydrochloride; Tetrahydrobiopterin

Indexed keywords

PHENYLALANINE; PHENYLALANINE 4 MONOOXYGENASE; SAPROPTERIN; TETRAHYDROBIOPTERIN;

EID: 67650230650     PISSN: 08835691     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TIN.0000318911.54358.a1     Document Type: Review
Times cited : (17)

References (29)
  • 1
    • 34848850451 scopus 로고    scopus 로고
    • The PAH gene, phenylketonuria, and a paradigm shift
    • Scriver CR. The PAH gene, phenylketonuria, and a paradigm shift. Hum Mutat. 2007;28(9):831-845.
    • (2007) Hum Mutat , vol.28 , Issue.9 , pp. 831-845
    • Scriver, C.R.1
  • 2
    • 0029786950 scopus 로고    scopus 로고
    • The influence of mutations on enzyme activity and phenylalanine tolerance in phenylalanine hydroxylase deficiency
    • Guttler F, Guldberg P. The influence of mutations on enzyme activity and phenylalanine tolerance in phenylalanine hydroxylase deficiency. Eur J Pediatr. 1996;155(suppl 1):S6-S10.
    • (1996) Eur J Pediatr , vol.155 , Issue.SUPPL. 1
    • Guttler, F.1    Guldberg, P.2
  • 3
    • 0034790129 scopus 로고    scopus 로고
    • National Institutes of Health Consensus Development Conference Statement. Phenylketonuria: screening and management, October 16-18, 2000. Pediatrics. 2001;108(4):972-982. http://consensus. nih.gov/2000/ 2000Phenylketonuria113html.htm.
    • National Institutes of Health Consensus Development Conference Statement. Phenylketonuria: screening and management, October 16-18, 2000. Pediatrics. 2001;108(4):972-982. http://consensus. nih.gov/2000/ 2000Phenylketonuria113html.htm.
  • 4
    • 34548416775 scopus 로고    scopus 로고
    • Waisbren SE, Noel K, Fahrbach K, et al. Phenylalanine blood levels and clinical outcomes in phenylketonuria: a systematic literature review and metaanalysis. Mol Genet Metab. June 23, 2007. (ahead of print)
    • Waisbren SE, Noel K, Fahrbach K, et al. Phenylalanine blood levels and clinical outcomes in phenylketonuria: a systematic literature review and metaanalysis. Mol Genet Metab. June 23, 2007. (ahead of print)
  • 5
    • 2942585422 scopus 로고    scopus 로고
    • Prevalence of stimulant use for attentional dysfunction in children with phenylketonuria
    • Arnold GL, Vladutiu CJ, Orlowski CC, Blakely EM, DeLuca J. Prevalence of stimulant use for attentional dysfunction in children with phenylketonuria. J Inherit Metab Dis. 2004;27(2):137-143.
    • (2004) J Inherit Metab Dis , vol.27 , Issue.2 , pp. 137-143
    • Arnold, G.L.1    Vladutiu, C.J.2    Orlowski, C.C.3    Blakely, E.M.4    DeLuca, J.5
  • 6
    • 34347340654 scopus 로고    scopus 로고
    • Executive functioning in children and adolescents with phenylketonuria
    • VanZutphen KH, Packman W, Sporri L, et al. Executive functioning in children and adolescents with phenylketonuria. Clin Genet. 2007;72(1):13-18.
    • (2007) Clin Genet , vol.72 , Issue.1 , pp. 13-18
    • VanZutphen, K.H.1    Packman, W.2    Sporri, L.3
  • 7
    • 34250023212 scopus 로고    scopus 로고
    • Meta-analysis of neuropsychological symptoms of adolescents and adults with PKU
    • Moyle JJ, Fox AM, Arthur M, Bynevelt M, Burnett JR. Meta-analysis of neuropsychological symptoms of adolescents and adults with PKU. Neuropsychol Rev. 2007;17(2):91-101.
    • (2007) Neuropsychol Rev , vol.17 , Issue.2 , pp. 91-101
    • Moyle, J.J.1    Fox, A.M.2    Arthur, M.3    Bynevelt, M.4    Burnett, J.R.5
  • 8
    • 0036744719 scopus 로고    scopus 로고
    • Phenylke-tonuria in adulthood: A collaborative study
    • Koch R, Burton B, Hoganson G, et al. Phenylke-tonuria in adulthood: a collaborative study. J Inherit Metab Dis. 2002;25(5):333-346.
    • (2002) J Inherit Metab Dis , vol.25 , Issue.5 , pp. 333-346
    • Koch, R.1    Burton, B.2    Hoganson, G.3
  • 9
    • 0025826561 scopus 로고
    • Agoraphobia in phenylke-tonuria
    • Waisbren SE, Levy HL. Agoraphobia in phenylke-tonuria. J Inherit Metab Dis. 1991;14(5):755- 764.
    • (1991) J Inherit Metab Dis , vol.14 , Issue.5 , pp. 755-764
    • Waisbren, S.E.1    Levy, H.L.2
  • 10
    • 25144483400 scopus 로고    scopus 로고
    • Living with phenylketonuria: Perspectives of patients and their families
    • Bilginsoy C, Waitzman N, Leonard CO, Ernst SL. Living with phenylketonuria: perspectives of patients and their families. J Inherit Metab Dis. 2005;28(5):639-649.
    • (2005) J Inherit Metab Dis , vol.28 , Issue.5 , pp. 639-649
    • Bilginsoy, C.1    Waitzman, N.2    Leonard, C.O.3    Ernst, S.L.4
  • 11
    • 0018867418 scopus 로고
    • Diet discontinuation policies and practices of PKU clinics in the United States
    • Schuett VE, Gurda RF, Brown ES. Diet discontinuation policies and practices of PKU clinics in the United States. Am J Public Health. 1980;70(5):498- 503.
    • (1980) Am J Public Health , vol.70 , Issue.5 , pp. 498-503
    • Schuett, V.E.1    Gurda, R.F.2    Brown, E.S.3
  • 12
    • 0037031064 scopus 로고    scopus 로고
    • How practical are recommendations for dietary control in phenylke-tonuria?
    • Walter JH, White FJ, Hall SK, et al. How practical are recommendations for dietary control in phenylke-tonuria? Lancet. 2002;360:55-57.
    • (2002) Lancet , vol.360 , pp. 55-57
    • Walter, J.H.1    White, F.J.2    Hall, S.K.3
  • 13
    • 1942540768 scopus 로고    scopus 로고
    • Iron status of children with phenylke-tonuria undergoing nutrition therapy assessed by transferrin receptors
    • Acosta PB, Yannicelli S, Singh RH, Elsas LJ II, Mofidi S, Steiner RD. Iron status of children with phenylke-tonuria undergoing nutrition therapy assessed by transferrin receptors. Genet Med. 2004;6(2):96-101.
    • (2004) Genet Med , vol.6 , Issue.2 , pp. 96-101
    • Acosta, P.B.1    Yannicelli, S.2    Singh, R.H.3    Elsas II, L.J.4    Mofidi, S.5    Steiner, R.D.6
  • 14
    • 0027393294 scopus 로고
    • Low iron stores in infants and children with treated phenylketonuria: A population at risk for iron-deficiency anaemia and associated cognitive deficits
    • Bodley JL, Austin VJ, Hanley WB, Clarke JT, Zlotkin S. Low iron stores in infants and children with treated phenylketonuria: a population at risk for iron-deficiency anaemia and associated cognitive deficits. Eur J Pediatr. 1993;152(2):140-143.
    • (1993) Eur J Pediatr , vol.152 , Issue.2 , pp. 140-143
    • Bodley, J.L.1    Austin, V.J.2    Hanley, W.B.3    Clarke, J.T.4    Zlotkin, S.5
  • 15
    • 0029786263 scopus 로고    scopus 로고
    • Nutrition studies in treated infants and children with phenylketonuria: Vitamins, minerals, trace elements
    • Acosta PB. Nutrition studies in treated infants and children with phenylketonuria: vitamins, minerals, trace elements. Eur J Pediatr. 1996;155(suppl 1):S136-S139.
    • (1996) Eur J Pediatr , vol.155 , Issue.SUPPL. 1
    • Acosta, P.B.1
  • 16
    • 0019940403 scopus 로고
    • Zinc status in growth of children undergoing treatment for phenylketonuria
    • Acosta PB, Fernhoff PM, Warshaw HS, et al. Zinc status in growth of children undergoing treatment for phenylketonuria. J Inherit Metab Dis. 1982;5(2):107-110.
    • (1982) J Inherit Metab Dis , vol.5 , Issue.2 , pp. 107-110
    • Acosta, P.B.1    Fernhoff, P.M.2    Warshaw, H.S.3
  • 18
    • 34250017342 scopus 로고    scopus 로고
    • Dietary long-chain polyunsaturated fatty acid supplementation in infants with phenylketonuria: A randomized controlled trial
    • Koletzko B, Sauerwald T, Demmelmair H, et al. Dietary long-chain polyunsaturated fatty acid supplementation in infants with phenylketonuria: a randomized controlled trial. J Inherit Metab Dis. 2007;30(3):326-332.
    • (2007) J Inherit Metab Dis , vol.30 , Issue.3 , pp. 326-332
    • Koletzko, B.1    Sauerwald, T.2    Demmelmair, H.3
  • 20
    • 0028154021 scopus 로고
    • Decreased bone mineral density in children with phenylketonuria
    • Allen JR, Humphries IR, Waters DL. Decreased bone mineral density in children with phenylketonuria. Am J Clin Nutr. 1994;59(2):419-422.
    • (1994) Am J Clin Nutr , vol.59 , Issue.2 , pp. 419-422
    • Allen, J.R.1    Humphries, I.R.2    Waters, D.L.3
  • 22
    • 33947635001 scopus 로고    scopus 로고
    • Peak bone mass in patients with phenylketonuria
    • Modan-Moses D, Vered I, Schwartz G. Peak bone mass in patients with phenylketonuria. J Inherit Metab Dis. 2007;30(2):202-208.
    • (2007) J Inherit Metab Dis , vol.30 , Issue.2 , pp. 202-208
    • Modan-Moses, D.1    Vered, I.2    Schwartz, G.3
  • 23
    • 67650241625 scopus 로고    scopus 로고
    • Burton B, Singh R. Paper presented at: American College Medical Genetics Annual Meeting; March 21-25, 2007. Abstract 310.
    • Burton B, Singh R. Paper presented at: American College Medical Genetics Annual Meeting; March 21-25, 2007. Abstract 310.
  • 24
    • 0026031086 scopus 로고
    • Effect of simultaneous inges-tion of l-amino acids and whole protein on plasma amino acid and urea nitrogen concentrations in humans
    • Gropper SS, Acosta PB. Effect of simultaneous inges-tion of l-amino acids and whole protein on plasma amino acid and urea nitrogen concentrations in humans. J Parenter Enteral Nutr. 1991;15(1):48-53.
    • (1991) J Parenter Enteral Nutr , vol.15 , Issue.1 , pp. 48-53
    • Gropper, S.S.1    Acosta, P.B.2
  • 25
    • 0036830284 scopus 로고    scopus 로고
    • Which weight for weight-based dosage regimens in obese patients?
    • Erstad B. Which weight for weight-based dosage regimens in obese patients? Am J Health Syst Pharm. 2002;59:2105-2110.
    • (2002) Am J Health Syst Pharm , vol.59 , pp. 2105-2110
    • Erstad, B.1
  • 26
    • 67650220803 scopus 로고    scopus 로고
    • PKU-005 Clinical Study Report. Novato, CA: BioMarin Pharmaceutical Inc; May 10, 2006.
    • PKU-005 Clinical Study Report. Novato, CA: BioMarin Pharmaceutical Inc; May 10, 2006.
  • 27
    • 36148953590 scopus 로고    scopus 로고
    • Recommendation for evaluation of responsiveness to tetrahydrobiopterin (BH4) in phenylke-tonuria and its use in treatment, molecular genetic metabolism
    • Levy HL. Recommendation for evaluation of responsiveness to tetrahydrobiopterin (BH4) in phenylke-tonuria and its use in treatment, molecular genetic metabolism. Mol Genet Metab. 2007;92:287-291.
    • (2007) Mol Genet Metab , vol.92 , pp. 287-291
    • Levy, H.L.1
  • 28
    • 84869372262 scopus 로고    scopus 로고
    • Updated August 25, 2004. Accessed August 28, 2007
    • Dietary Reference Intakes, NIH Office of Dietary Supplements. http://dietary-supplements.info.nih.gov/ Health-Information/Dietary-Reference- Intakes.aspx. Updated August 25, 2004. Accessed August 28, 2007.
    • Dietary Reference Intakes, NIH Office of Dietary Supplements
  • 29
    • 33745790867 scopus 로고    scopus 로고
    • Protein substitute dosage in PKU: How much do young patients need?
    • MacDonald A, Chakrapani A, Hendriksz C, et al. Protein substitute dosage in PKU: how much do young patients need? Arch Dis Child. 2006;91(7):588-593.
    • (2006) Arch Dis Child , vol.91 , Issue.7 , pp. 588-593
    • MacDonald, A.1    Chakrapani, A.2    Hendriksz, C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.